All analyses performed in the clinical biochemistry laboratory should be assessed through interlaboratory quality assurance survey. A plethora of such surveys of regional, national, and international natures exist for those analytes in serum or plasma which are the major source of work for the clinical biochemist. In contrast, there are few reports on the design and execution of quality assurance surveys concerned with the performance of analysis of other body fluids. Although quantitative analysis of urine represents a minor but nevertheless important component of the workload of most laboratories, there are, with the exception of the urine surveys of the College of American Pathologists,'-3 few reports on quality assurance programmes for analytes in this biological fluid. In 1980 a small scale regional survey of the performance of quantitative analysis of urinary analytes was therefore carried out in South Australia as a necessary prerequisite to the future establishment of an Australasian urine quality assurance survey.4 Under the auspices of the Australian Association of Clinical Biochemists and the Royal College of Pathologists of Australasia, a programme was instituted in 1981 to assess the standard of performance *Present address: Department of Biochemical Medicine,-NinewelsHospital and Medical School, University of Dundee, Dundee DD1 9SY, Scotland. Acceptedfor publication -15 December 1983 of the quantitative analysis of 10 urinary constituents throughout Australasia.5 The constituents surveyed were sodium, potassium, osmolality, urea, creatinine, calcium, phosphate, urate, proteins, and glucose. The programme was also designed to provide rapid feedback to participants on their comparative performance and included novel features such as the use of target values, allowable limits for total laboratory error, linearly related analyte concentrations for all samples distributed, and computer generation of graphic interim and final reports.
In 1982, the Australasian Urine Programme was similarly conducted,6 with the range of analytes surveyed being extended to include chloride, oxalate, 4-hydroxy-3-methoxymandelic acid (HMMA), and 5-hydroxyindoleacetic acid (5HIAA).
In 1983 a further survey was conducted in order to provide continuing review of the standard of performance of urine analyses. ' The range of analytes was further extended to include amylase (EC 3.2.2.1).
Through the evolution of the Australasian Urine Programme over the past three years, a number of analytical problems have been highlighted and the standard of performance achieved by laboratories for certain urine chemistries has improved substantially. This paper summarises the programmes implemented and the results obtained over the three years and reviews the progress made towards attempting to raise the standard of performance of in 1981, 1982, and 1983 respectively to all participants together with a detailed instruction sheet and colour coded result sheets.
In 1981, all survey samples were generated in the laboratory of the survey organisers from a single lot of Ortho Control Urine I (Ortho Diagnostics, Raritan, NJ 08869). An appropriate number of vials were reconstituted with a defined volume of reconstitution material to generate a series of samples with linearly related concentrations. After reconstitution, 10 ml aliquots were dispensed into labelled plastic tubes, and these liquid samples were then distributed to participants by air cargo.
In 1982 vials of lyophilised urine quality control material, to be reconstituted by the participating laboratory, were distributed by the survey organ- Overall imprecision (SD) was calculated as the standard error of the estimate about the line of best fit and was considered to reflect the average laboratory SD over the range of results submitted. Imprecision and bias were also ranked from the lowest to the highest value. The median value was selected as the "average laboratory performance" for the parameter concerned.
Results and discussion
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Other materials used as calibrants that are not 5H1AA (gmol/1) ±20 at G100 detailed in Table 4 include commercial cerebrospiAmylase (UIl) ±20% at >100 nal fluid and serum quality control material and National Bureau of Standards (Washington, DC 20234) material for the calibration of urea and calcium analyses. We believe that calibration materials should have a matrix similar to, if not identical with, buted were used as the extremes of the linear regres-the fluid being analysed, and therefore consider that sion. Bias was calculated from the formula: the use of serum based material for the calibration 1981 1982 1983 1981 1982 1983 1981 1982 1983 1981 1982 1983 1981 1982 1983 1981 1982 1983 Sodium 72  73  86  48  63  60  6  3  1  34  25  31  5  3  1  7  4  6  Potassium 72  73  86  48  63  60  6  3  1  34  25  31  5  3  1  7  4  6  Osmolality 53  48  57  32  35  46   -2   -38  31  37  21  27  16  9  2  2  Urea  69  61  65  43  44  48  1  2  3  46  44  46  1  2   -6  5  2  Creatinine 84  72  85  46  56  53  6  1  2  43  37 Consistent decline over Proteins three years ory error, as defined in Table 3 , have been used for each survey. We therefore consider that the percentage of unacceptable results represents an appropriate parameter to observe trends in overall analytical performance over the three year period. The percentages of unacceptable results submitted for all participating laboratories and for the selected group of 47 laboratories that have participated in all three urine surveys are shown in Table 7 . The trends in analytical performance observed, which are similar for all laboratories compared with the group of 47 laboratories that participated in all three surveys, are summarised in Table 8 . (Table  10) with the analytical goals, it can be seen that the analytical goals can be achieved, and in some instances have been surpassed, by this group of laboratories for urine sodium, potassium, osmolal- 1981 1982 1983 1981 1982 1983 1981 1982 1983 1981 1982 1983 1981 1982 1983 1981 1982 1983 Sodium (mmol/l) 2-8 3-9 1-4 1-7 2-1 2-1 2-6 3-9 1-5 1-6 2-1 2-2 1-1 0 9 0-6 0 7 0-5 0 9 Potassium (mmol/ 1981 1982 1983 1981 1982 1983 1981 1982 1983 1981 1982 1983 1981 1982 1983 1981 1982 1983 Sodium (mmol/1) 3-8 6-1 2-0 2-3 3-2 2-9 3-7 6-0 2-0 2-3 3-2 2-9 1-4 1-3 0-6 0 9 0-7 0-8 Potassium (mmol/1) 1-7 1-5 1-5 2-5 3-8 2-7 1-2 1-6 1-3 1-8 4 0 2-4 0-6 0-6 0-2 0-9 1-4 0-4
Osmolality ( ity, creatinine, calcium, and phosphate. Furthermore, imprecision, in SD terms, has continued to improve for urine sodium, osmolality, and phosphate.
Over the three year period more than 5% of results submitted were classed as blunders, in at least two of the three years, for the analyses of osmolality, urea, calcium, urate, proteins, oxalate, and 5HIAA. As well as being due to inherently poor analytical technique, blunders were mainly attributed to transcription, dilution, or calculation mistakes. For osmolality we recommend that attention should also be paid to calibration with a material which has an analyte concentration similar to that of routine urine specimens. For urate it was evident that some laboratories were not aware that urate precipitates in an acidic urine and, as a result, did not take the preanalytical precaution of alkalinising urine specimens submitted for urate analysis."
COMPARISON OF INDIVIDUAL METHODS FOR EACH ANALYTE
A critical assessment of the suitability of individual methods for routine laboratory use has been attempted using the data summarised in Table 13 Evolution of a national urine quality assurance programme: the Australasian experience, 1981-1983 421 1981 1982 1983 1981 1982 1983 1981 1982 1983 1981 1982 1983 1981 1982 1983 36 38 2-8 3-9 1-4 3-8 6-1 2-0 30 39 1-0 4-2 6-1 2-0 3-2 3-6 1-5 3-7 6-2 1-3 2-3 1-2 1-6 1-5 34 1-9
1-1 0-8 1-4 1-7 1-5 1-5 1-3 0-8 1-2 1-1 1-3 1-4 3-9 1-0 1-4 3-3 1-3 1-8 0-9 0-8 1-6 1-5 2-1 1-4 9-8 7-6 5-8 15-8 18-7 7 5 15-9 9-0 -15-7 19-0 -13-5 9 3 5-8 23-1 24-7 7-1 8-1 4-2 5-0 13-4 10-1 6-6 4-6 7-1 4-3 14-1 18-6 6-2 10-6 10-0 9-6 14-4 27-3 12-2 25-3 11-0 13-8 25-8 12-5 11-0 25-5 10-7 11-8 23-3 10-0 9-2 28-6 15-3 22-0 32-3 12-2 21-9 For abbreviations see Table 13 . For abbreviations see Table 13 .
Two methods-namely, metal complex reduction for the analysis of urinary urate and sulphosalicyclic acid turbidimetry for urine protein assay-are considered to be unsuitable for routine urine analyses. These two methods have, for two years in succession, had more than 70% of results submitted outside the allowable limits of error. Metal complex reduction was accordingly discontinued in the 1983 urine survey. In 1982 the high level of unacceptable results for the sulphosalicyclic acid turbidimetric method was considered to reflect the fact that the Shephard, Penberthy, Fraser survey material, in that year, contained a small amount of bovine albumin. The continued high level of unacceptable results recorded by this method in 1983 using a totally human based matrix, however, raises serious doubts as to the validity of this method for routine analytical purposes.
Methods assessed as having shown poor performance and good performance, using the criterion that the percentage of unacceptable results, for at least two out of three years, was >35% or <10% respectively, are shown in Table 14 . Table 13 also shows the median imprecision and bias for individual methods. Such data were calculated for those method groups in which 36 or more results were submitted in a particular year. The median value was chosen, again, since it was considered to reflect the "average" performance of an individual method group. For the reasons outlined earlier in this paper, it is difficult to draw conclusions on the comparative performance of methods in terms of trends over a three year period. By comparing the differences in magnitude of the imprecision and bias, expressed in absolute terms, between individual methods within a given year, however, objective conclusions are possible.
Methods considered to show poor and good performance characteristics, in terms of imprecision and bias, are listed in Table 15 . The criterion used for classifying methods into these categories was that if the median imprecision or bias or both of a particular method was 25% better (or worse) than the " all method" median imprecision or bias or both for a particular analyte for at least two out of the three years, then that particular method was deemed to display good (or poor) imprecision or bias or both respectively.
Throughout the Australasian urine quality assurance programme individual participants have been urged to examine critically the summary of their performance and assess the imprecision, inaccuracy, and linearity of their methods. At the end of the third year the survey organisers believed that the wealth of data generated from these surveys should be summarised in a manner which all laboratories could use positively to achieve a generally higher standard of performance in the future. We hope that this report facilitates this aim.
